Digital Health Pioneer Turns Personal Battle with Cancer into AI-Powered CureWise Platform
A new wave of artificial intelligence in healthcare is being spearheaded by a veteran of the digital health space, who is leveraging large language models (LLMs) to create a personalized AI doctor. The platform, called CureWise, is the brainchild of an industry leader who recently faced a personal health crisis, demonstrating the potential for AI to revolutionize patient care.
A seasoned innovator, Steve Brown, is widely recognized as a pioneer in the field. His career began with the development of video games designed to assist children managing diabetes. He then founded Health Hero, one of the earliest companies focused on disease management, which was later adopted by the Department of Veterans Affairs to remotely monitor patients with conditions such as congestive heart failure (CHF) and diabetes before being acquired by Bosch.
After a 15-year hiatus from healthcare, Brown’s own diagnosis of cancer earlier in 2025 prompted him to explore the possibilities of AI. “He turned to AI and has built an amazing early stage patient facing AI doctor,” one analyst noted. CureWise effectively transforms LLMs into a virtual team of medical specialists, offering patients a readily accessible source of information and support.
The platform’s development was deeply personal for Brown, who serves as both CEO and “patient zero,” utilizing CureWise as his primary tool throughout his own treatment. “This is clearly the future but it’s also the present for Steve,” according to a recent report. He provided a comprehensive demonstration of the platform’s capabilities, highlighting its potential to empower patients and improve healthcare outcomes.
The emergence of CureWise underscores a growing trend within the health tech sector: the application of AI to address critical needs in patient care and personalized medicine. As LLMs continue to evolve, their capacity to deliver accessible, informed, and individualized healthcare solutions will likely expand, reshaping the landscape of medical treatment.
